Schering and U.S. affiliate Berlex are voluntarily recalling all lots of its Ultravist Injection 370 mgI/mL x-ray contrast agent as part of a worldwide recall.
The firms are recalling the agents due to the potential that particulate matter in conjunction with crystallization may be present in the product. Potential for serious safety problems include thrombosis of blood vessels, thromboembolism, and injury or infarction of end organs such as heart, kidney, and brain, according to Schering of Berlin and Berlex of Wayne, NJ.
On July 20, Berlex announced the recall of a single lot of Ultravist.
The worldwide recall does not include other concentrations of Ultravist. In addition, production of Ultravist 370 mgI/mL in China and South Korea is not affected, and domestic supply in these two countries will continue, Schering said.
Proscope 370 mgI/mL in Japan and Clarograf 370 mgI/mL in Spain are affected by the recall, Schering said.
By AuntMinnie.com staff writers
July 31, 2006
Related Reading
Berlex issues Ultravist recall for U.S., July 21, 2006
Schering, Avid partner on Alzheimer's agents, July 17, 2006
Bayer reaches 88% stake in Schering, June 21, 2006
Schering divests CIS radiopharma unit, May 8, 2006
Berlex gets Magnevist renewal, August 4, 2005
Copyright © 2006 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
